cobas e801 Immunoassay Analyzer

FDA Device Recall #Z-1515-2022 — Class II — July 14, 2022

Recall Summary

Recall Number Z-1515-2022
Classification Class II — Moderate risk
Date Initiated July 14, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Diagnostics Operations, Inc.
Location Indianapolis, IN
Product Type Devices
Quantity 965 units

Product Description

cobas e801 Immunoassay Analyzer

Reason for Recall

Software issue resulting in signals and sample test results of Pre-Wash tests being impacted. The following assays are considered impacted by the issue: Anti-HAV2, Anti-HBc IgM, IGF-1, Myogloin, Rubella IgG, and Toxo IgG.

Distribution Pattern

US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, DC & PR.

Lot / Code Information

UDI-DI: 07613336158456 and 04015630946198; Catalog No. 08454345001 and 07682913001. All serial numbers.

Other Recalls from Roche Diagnostics Operations, Inc.

Recall # Classification Product Date
Z-1476-2026 Class II cobas pro integrated solutions with cobas c 503... Jan 20, 2026
Z-1009-2026 Class II The Elecsys Anti-TSHR immunoassay is a three-st... Nov 21, 2025
Z-0489-2025 Class II cobas HCYS, Homocysteine Enzymatic Assay, Mater... Oct 17, 2024
Z-3187-2024 Class II Creatine Kinase (CK) used on cobas c 311/501/50... Aug 15, 2024
Z-0352-2024 Class II Tina-quant D-Dimer Test System, Fibrinogen/Fibr... Oct 3, 2023

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.